ABSTRACT
PURPOSE: The prevalence of trachomatous inflammation-follicular (TF) in Papua New Guinea (PNG) suggests antibiotic mass drug administration (MDA) is needed to eliminate trachoma as a public health problem but the burden of trichiasis is low. As a result, WHO issued bespoke recommendations for the region. If ≥ 20% of 10-14-year-olds have both any conjunctival scarring (C1 or C2 or C3) and corneal pannus and/or Herbert's pits, MDA should be continued. Equally, if ≥ 5% of that group have both moderate/severe conjunctival scarring (C2 or C3) and corneal pannus and/or Herbert's pits, MDA should be continued. METHODS: We identified 14 villages where > 20% of 1-9-year-olds had TF during baseline mapping undertaken 4 years and 1 month previously. Every child aged 10-14 years in those villages was eligible to be examined for clinical signs of corneal pannus, Herbert's pits and conjunctival scarring. A grading system that built on existing WHO grading systems was used. RESULTS: Of 1,293 resident children, 1,181 (91%) were examined. Of 1,178 with complete examination data, only one (0.08%) individual had concurrent scarring and limbal signs. CONCLUSIONS: The WHO-predefined criteria for continuation of MDA were not met. Ongoing behavioural and environmental improvement aspects of the SAFE strategy may contribute to integrated NTD control. Surveillance methods should be strengthened to enable PNG health authorities to identify future changes in disease prevalence.
ABSTRACT
Baseline mapping in the two major population centers of Kiribati showed that trachoma was a public health problem in need of programmatic interventions. After conducting two annual rounds of antibiotic mass drug administration (MDA), Kiribati undertook trachoma impact surveys in 2019, using standardized two-stage cluster surveys in the evaluation units of Kiritimati Island and Tarawa. In Kiritimati, 516 households were visited and in Tarawa, 772 households were visited. Nearly all households had a drinking water source and access to an improved latrine. The prevalence of trachomatous trichiasis remained above the elimination threshold (0.2% in ≥15-year-olds) and was virtually unchanged from baseline. The prevalence of trachomatous inflammation-follicular (TF) in 1-9-year-olds decreased by approximately 40% from baseline in both evaluation units but remained above the 5% TF prevalence threshold for stopping MDA. TF prevalence at impact survey was 11.5% in Kiritimati and 17.9% in Tarawa. Infection prevalence in 1-9-year-olds by PCR was 0.96% in Kiritimati and 3.3% in Tarawa. Using a multiplex bead assay to measure antibodies to the C. trachomatis antigen Pgp3, seroprevalence in 1-9-year-olds was 30.2% in Kiritimati and 31.4% in Tarawa. The seroconversion rate, in seroconversion events/100 children/year, was 9.0 in Kiritimati and 9.2 in Tarawa. Seroprevalence and seroconversion rates were both assessed by four different assays, with strong agreement between tests. These results show that, despite decreases in indicators associated with infection at impact survey, trachoma remains a public health problem in Kiribati, and provide additional information about changes in serological indicators after MDA.
Subject(s)
Trachoma , Child , Humans , Infant , Trachoma/drug therapy , Trachoma/epidemiology , Azithromycin/therapeutic use , Mass Drug Administration , Seroepidemiologic Studies , Chlamydia trachomatis , Anti-Bacterial Agents/therapeutic use , Prevalence , MicronesiaABSTRACT
BACKGROUND: The epidemiology of trachoma in several Pacific Islands differs from other endemic settings, in that there is a high prevalence of clinical signs of trachoma, particularly trachomatous inflammation-follicular (TF), but few cases of trichiasis and limited evidence of ocular chlamydial infection. This so-called "Pacific enigma" has led to uncertainty regarding the appropriate public health response. In 2019 alongside Nauru's national trachoma population survey, we performed bacteriological and serological assessments of children to better understand the typology of trachoma and to determine whether there is a need for trachoma interventions. METHODS: We used two-stage cluster sampling, examining residents aged ≥1 year and collecting household-level water, sanitation, and hygiene (WASH) variables. Children aged 1-9 years provided conjunctival swabs and finger-prick dried blood spots to investigate the presence of Chlamydia trachomatis nucleic acid and anti-Pgp3 antibodies, respectively. PRINCIPAL FINDINGS: In 818 participants aged 1-9 years, the age-adjusted TF prevalence was 21.8% (95% CI 15.2-26.2%); ocular C. trachomatis prevalence was 34.5% (95% CI 30.6-38.9), and anti-Pgp3 antibody prevalence was 32.1% (95% CI 28.4%-36.3%). The age- and gender-adjusted prevalence of trichiasis in ≥15-year-olds was 0.3% (95% CI 0.00-0.85), but no individual with trichiasis had trachomatous scarring (TS). Multivariable analysis showed an association between age and both TF (OR per year of age 1.3 [95% CI 1.2-1.4]) and anti-Pgp3 positivity (OR 1.2 [95% CI 1.2-1.3]). There were high rates of access to water and sanitation and no WASH variable was associated with the presence of TF. CONCLUSIONS: TF, nucleic acid, and age-specific antibody prevalence collectively indicate that high levels of C. trachomatis transmission among children present a high risk of ocular damage due to trachoma. The absence of trichiasis with trachomatous scarring suggest a relatively recent increase in transmission intensity.
Subject(s)
Infant, Newborn, Diseases , Nucleic Acids , Trachoma , Trichiasis , Child , Chlamydia trachomatis , Cicatrix/epidemiology , Humans , Hygiene , Infant , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Prevalence , Sanitation , Trachoma/diagnosis , Trachoma/epidemiology , Trichiasis/epidemiology , WaterSubject(s)
Blindness/prevention & control , Eye Diseases/therapy , Global Health , Health Services Accessibility/organization & administration , Sustainable Development , Advisory Committees/organization & administration , Blindness/economics , Blindness/etiology , Cost of Illness , Eye Diseases/complications , Eye Diseases/diagnosis , Eye Diseases/epidemiology , Global Burden of Disease/economics , Health Services Accessibility/economics , Humans , Quality of Health Care/economics , Quality of Health Care/organization & administration , Quality of LifeABSTRACT
BACKGROUND: In the Solomon Islands and Vanuatu, the sign trachomatous inflammation-follicular (TF) is common, but ocular infection with Chlamydia trachomatis is not. It is therefore debatable whether azithromycin mass drug administration (MDA), the recommended antibiotic treatment strategy for trachoma's elimination as a public health problem, is necessary in this setting. We set out to estimate what proportion of adolescents were at risk of progression of trachomatous scarring. METHODS: A cross-sectional survey was undertaken of all children aged 10-14 years resident in communities identified as high-TF clusters during previous population-based mapping. Graders examined children for clinical evidence of trachomatous scarring, pannus, and Herbert's pits (HPs) or limbal follicles in both eyes. A dried blood spot was collected from each child and tested for antibodies to C. trachomatis. RESULTS: A total of 492 children in 24 villages of the Solomon Islands and Vanuatu were examined. In total, 35/492 (7%) of children had limbal signs (pannus and/or HPs) plus any conjunctival scarring. And 9/492 (2%) had limbal signs and moderate or severe conjunctival scarring; 22% of children were anti-Pgp3 seropositive. CONCLUSIONS: Few adolescents here are at risk of future complications from trachoma, supporting the conclusion that further antibiotic MDA is not currently required for trachoma elimination purposes in these settings.
Subject(s)
Trachoma , Adolescent , Child , Cicatrix/epidemiology , Cross-Sectional Studies , Humans , Melanesia/epidemiology , Pannus , Trachoma/drug therapy , Trachoma/epidemiology , VanuatuABSTRACT
Yaws is a neglected tropical disease targeted for eradication by 2020. Kiribati, a Pacific Island nation, was previously endemic for yaws but lacks recent data from which its current endemicity status could be determined. This study tested antibody responses to Treponema pallidum to determine if transmission of yaws is taking place among children in Kiribati. Using a commercially available T. pallidum particle agglutination kit (Serodia®, Fujirebio Inc., Tokyo, Japan), we tested dried blood spots, collected during population-based trachoma prevalence surveys on Tarawa Atoll and Kiritimati Island, for long-lived treponemal antibodies. Dried blood spots from 1,420 children aged 1-9 years were tested. Only two were positive, suggesting T. pallidum is not being widely transmitted among children in the settings sampled. These data require support from additional surveys to demonstrate the absence of clinical signs of disease and molecular evidence of infection, to confirm that yaws is no longer endemic in Kiribati.
Subject(s)
Antibodies, Bacterial/blood , Yaws/blood , Yaws/epidemiology , Adolescent , Agglutination Tests , Child , Child, Preschool , Dried Blood Spot Testing , Endemic Diseases/statistics & numerical data , Female , Humans , Infant , Male , Micronesia/epidemiology , Prevalence , Treponema pallidumABSTRACT
OBJECTIVE: To establish the prevalence and causes of low vision and blindness in children aged 0 to 15 years in Fiji using existing data and new surveys. Method Childhood visual impairment data on both low visual acuity (<20/60-20/400) and blindness (<20/400) were obtained from existing records at hospital clinics, the school, an outreach service for visually impaired children, primary school screening records, and surveys in high schools and schools for children with multiple disabilities. Crude prevalence was derived and, using 5-year age range and age at onset of vision loss, the probable prevalence per 1000 children was calculated. RESULTS: A total of 81 children were identified; causes were established for 70 children, showing that 69% had unavoidable causes of vision loss (retinal, 39.7% and cortical, 15.5%), with the avoidable cause of low vision and blindness mainly being cataract (15.5%). Probable prevalence was 1.134 per 1000 children (95% confidence interval [CI], 1.115-1.153), with low vision, 0.774 per 1000 children (95% CI, 0.758-0.790) and blindness, 0.36 per 1000 children (95% CI, 0.349-0.371). The rate of severe visual impairment (<20/200) was 0.522 per 1000 children (95% CI, 0.509-0.535), only half of the total vision loss. CONCLUSIONS: Both the low to moderate prevalence and mainly unavoidable causes of visual impairment indicated that Fiji, a developing country, has prevalence and causes of visual impairment similar to more resourced, industrialized countries.